Found programs: National Key Research and Development Program of China (No . 2020YFA0907400) ; National Natural Science Foundation of China (No . 32170702)
Authors:Qiu Yaxuan1 , Meng Xiangrui 1 , Xie Xiaoyan2 , Cheng Sitong1 , Peng Yufan2 , Liu Siqi 1 , Zhao Xue2 , 3 , Hu Zhangfeng2 , 3 , Xing Junqiao2 , 3 , Wang Weihua2 , 3
Keywords:FAM50A; antibody preparation; gene knockout; cilia; pancreas; diabetes mellitus
DOI:10.19405/j.cnki.issn1000-1492.2025.11.016
〔Abstract〕 To construct a Family with sequence similarity 50 member A ( FAM50A) gene knockout mouse insulinoma pancreatic β-cell line Beta-TC-6 using CRISPR/Cas9 gene editing technology and to prepare polyclonal antibodies specifically recognizing FAM50A . Methods Two guide RNAs ( sgRNAs) targeting the FAM50A gene were designed , and a recombinant plasmid expressing blue fluorescent protein (BFP) was construc- ted for gene knockout. The successfully constructed plasmid was transfected into Beta-TC-6 cells , and BFP-positive single cells were isolated for clonal expansion . The expanded monoclonal cell lines were genotyped by Sanger se- quencing , and FAM50A protein expression was assessed by Western blot. Purified human recombinant FAM50A protein was used to immunize New Zealand rabbits for the preparation of a polyclonal antibody . The specificity of the prepared antibody was then validated using the successfully established FAM50A knockout cell line . Results A monoclonal cell line with a successful knockout of the FAM50A gene was identified . Sanger sequencing confirmed base deletions at the target site . Western blot analysis showed a complete absence of FAM50A protein expression in this cell line . The prepared polyclonal antibody successfully recognized endogenous murine FAM50A protein in wild-type Beta-TC-6 cells and in hTERT-RPE1 cells overexpressing human FAM50A-GFP fusion protein , while no signal was detected in the FAM50A knockout cells . Conclusion This study successfully established a FAM50A gene knockout Beta-TC-6 cell model and generated a FAM50A polyclonal antibody , providing powerful tools for fu- ture research .